Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vertex posts loss as hepatitis drug sales fall
Reuters
Friday, November 2, 2012 - 9:52am
tags:
earnings, Vertex Pharmaceuticals
Why Arena's Launch Will Be Strong, Despite Vivus' Weak Launch
Motley Fool
Thursday, November 1, 2012 - 6:09pm
tags:
Arena Pharmaceuticals, obesity, Vivus, Belviq, Qsymia
Johnson & Johnson Settles 845 Levaquin Lawsuits
Bloomberg
Thursday, November 1, 2012 - 6:07pm
tags:
JNJ, settlements, Levaquin
Endocyte Reports Third Quarter 2012 Financial Results and Business Update
Yahoo
Thursday, November 1, 2012 - 6:07pm
tags:
earnings, Endocyte
Pfizer's Future May Hinge On Tofacitinib FDA Action In November
Seeking Alpha
Thursday, November 1, 2012 - 6:06pm
tags:
FDA, Pfizer, tofacitinib, rheumatoid arthritis
The Gory Details on GlaxoSmithKline's Double Miss
Motley Fool
Thursday, November 1, 2012 - 5:19pm
tags:
GSK, earnings
Pfizer says to make "go or no go" decision by March 2013 on Remoxy
Reuters
Thursday, November 1, 2012 - 12:42pm
tags:
Remoxy, Pfizer
Sanofi draws fire over cost of MS drug Lemtrada
Reuters
Thursday, November 1, 2012 - 11:51am
tags:
MS, multiple sclerosis, Sanofi, Lemtrada
Medivation Prostate Cancer Drug Launches Hot
TheStreet.com
Thursday, November 1, 2012 - 11:50am
tags:
Medivation, prostate cancer, Astellas, Xtandi
Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover
Bloomberg
Thursday, November 1, 2012 - 11:49am
tags:
Medivir, hepatitis C, VX-135, Vertex Pharmaceuticals
The Wild October Ride Of Vivus
Seeking Alpha
Thursday, November 1, 2012 - 11:25am
tags:
Vivus, obesity, Arena Pharmaceuticals
Novartis to Construct $500M Biologics Plant in Singapore
Genetic Engineering News
Thursday, November 1, 2012 - 11:20am
tags:
Novartis, Singapore
Watson CEO Looks Past Actavis Deal to Next Growth Plans
Bloomberg
Thursday, November 1, 2012 - 11:19am
tags:
Watson, Pharma CEOs, Actavis, M&A, generics
Bayer to buy U.S. vitamin maker Schiff for $1.2 bln
Reuters
Thursday, November 1, 2012 - 11:18am
tags:
Bayer, M&A, Schiff, vitamins
GlaxoSmithKline warns on European drug prices
Guardian, UK
Thursday, November 1, 2012 - 11:17am
tags:
Europe, GSK, drug pricing
Isis Means Business With This New Treatment
Wall St. Cheat Sheet
Thursday, November 1, 2012 - 11:16am
tags:
Isis Pharmaceuticals, ISIS-STAT3, chemotherapy, advanced cancer, cancer
Somaxon Pharmaceuticals, Inc.'s CEO Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha
Thursday, November 1, 2012 - 11:15am
tags:
Somaxon, earnings
Pfizer sees emerging market sales rising in "high single digit" percentage range
Reuters
Thursday, November 1, 2012 - 11:14am
tags:
Pfizer, emerging markets
Eli Lilly: Cymbalta Patent Cliff
Seeking Alpha
Thursday, November 1, 2012 - 10:57am
tags:
patent cliff, Eli Lilly, Cymbalta
Pfizer Profit Matches Estimates as Forcast Range Narrows
Bloomberg
Thursday, November 1, 2012 - 10:08am
tags:
Pfizer, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.